Essex Investment Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Sell |
381,595
-2,730
| -0.7% | -$25.3K | 0.64% | 51 |
|
|
2025
Q1 | $2.82M | Sell |
384,325
-2,923
| -0.8% | -$21.4K | 0.59% | 63 |
|
|
2024
Q4 | $3.31M | Sell |
387,248
-56,429
| -13% | -$482K | 0.59% | 64 |
|
|
2024
Q3 | $3.86M | Buy |
443,677
+1,168
| +0.3% | +$10.2K | 0.67% | 52 |
|
|
2024
Q2 | $3.03M | Buy |
442,509
+66,309
| +18% | +$454K | 0.57% | 65 |
|
|
2024
Q1 | $3.42M | Buy |
376,200
+5,828
| +2% | +$53K | 0.68% | 48 |
|
|
2023
Q4 | $1.65M | Buy |
+370,372
| New | +$1.65M | 0.33% | 118 |
|
|
2023
Q3 | – | Sell |
-300,977
| Closed | -$1.55M | – | 385 |
|
|
2023
Q2 | $1.55M | Buy |
+300,977
| New | +$1.55M | 0.22% | 150 |
|
|
2015
Q4 | – | Sell |
-11,485
| Closed | -$161K | – | 323 |
|
|
2015
Q3 | $161K | Buy |
+11,485
| New | +$161K | 0.03% | 296 |
|